cupure logo
tradedealtrumptrade dealtariffspaytarifftrumpschinayear

Sarepta will resume gene therapy shipments after FDA review of recent patient death

Sarepta will resume gene therapy shipments after FDA review of recent patient death
Shares of drugmaker Sarepta Therapeutics surged in afterhours trading Monday after the company said it would resume shipping its gene therapy

Comments

Business News